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ABSTRACT
Purpose Skin provides an excellent portal for diagnostic
monitoring of a variety of entities; however, there is a dearth
of reliable methods for patient-friendly sampling of skin
constituents. This study describes the use of low-frequency
ultrasound as a one-step methodology for rapid sampling of
molecules from the skin.
Methods Sampling was performed using a brief exposure of
20 kHz ultrasound to skin in the presence of a sampling fluid. In
vitro sampling from porcine skin was performed to assess the
effectiveness of the method and its ability to sample drugs and
endogenous epidermal biomolecules from the skin. Dermal
presence of an antifungal drug—fluconazole and an abused
substance, cocaine—was assessed in rats.
Results Ultrasonic sampling captured the native profile of
various naturally occurring moisturizing factors in skin. A high
sampling efficiency (79±13%) of topically delivered drug was
achieved. Ultrasound consistently sampled greater amounts of
drug from the skin compared to tape stripping. Ultrasonic
sampling also detected sustained presence of cocaine in rat skin
for up to 7 days as compared to its rapid disappearance from
the urine.
Conclusions Ultrasonic sampling provides significant advan-
tages including enhanced sampling from deeper layers of skin
and high temporal sampling sensitivity.
KEY WORDS drugs.forensic.sampling.tapestripping.
ultrasound
INTRODUCTION
Skin, the outermost organ of the human body, acts as a
reservoir for chemicals that come in its contact either
because of topical drug application or because of un-
intended exposure to entities such as pollutants or industrial
chemicals (1). Several systemically administrated chemicals,
including therapeutic and abused drugs, also accumulate
in the skin over a period of time (2–5). Accordingly, a
quantitative assessment of skin’s chemical composition has
potential applications in varied fields, including therapeutic
drug monitoring and exposure assessment. However, the
lack of reliable methods for standardized and patient-
friendly sampling of skin’s constituents has significantly
hampered translation of skin-based diagnostic methods into
the clinic (6).
Over the years, a handful of methods have been
reported for direct sampling of molecular components of
the skin. Earliest methods include removal of skin strata by
shave/punch biopsies and analyses of molecular constitu-
ents in the liquefied biopsy samples (7). Methods have also
been developed to harvest skin’s interstitial fluid through
suction-blisters or microdialysis (8). However, applications
of these techniques in the clinic have been limited by their
invasiveness and practical challenges. As opposed to these
invasive methods of varying degree, the tape-stripping
technique, which requires an adhesive to bind and collect
the contents of the skin surface, has been used for sampling
skin, specifically its outermost layer—stratum corneum (SC)
(9). Traditionally, the tape-stripping method has been
reported to be limited by lack of a standardized protocol
(10,11) and high site-to-site sampling heterogeneity (12);
however, several recent studies have advanced this technique
to more accurately determine the pharmacokinetic profile of
drugs in skin and control the sampling variability (13–17).
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applies low intensities of current through skin, has reported
excellent capabilities to sample glucose, lithium, phenytoin,
valproate, lactate and urea from the skin (18). In another
technique, low-frequency ultrasound has also been used to
sample interstitial fluid through a two-step process: first, by
permeabilizing the skin by ultrasound and subsequently, by
applying vacuum to collect interstitial fluid (19–21).
Herein, we describe the use of low-frequency ultrasound
as a rapid and one-step sampling methodology for
determination of chemicals. We specifically describe quan-
titative sampling of skin’s natural moisturizing factors
(a family of molecules critical for skin’s hydration, mechan-
ical strength and metabolic activities) as well as exogenous
therapeutic drug molecules and drugs-of-abuse in the skin.
Detailed in vitro and in vivo experimental results character-
izing this methodology’s sampling efficiency as compared
with tape-stripping technique are also presented.
METHODS
Skin Procurement and Animals Models
In vitro sampling experiments were performed on porcine
skin. Full-thickness porcine skin was harvested from the
lateral abdominal region of Yorkshire pigs, adipose tissue
was stripped and skin was sectioned into 10 cm×25 cm
pieces by Lampire Biological Laboratories Inc., PA. Skin
pieces were shipped over dry ice and stored at −70°C upon
receipt until the experiment. Skin pieces with no visible
imperfections such as scratches and abrasions were thawed
at room temperature and used for experiments. Skin was
further cut into small pieces (2.5 cm×2.5 cm).
In vivo experiments were performed using Female
Sprague Dawley rats (8–10 weeks, Charles River Laboratory,
Wilmington, MA). All animal handling and maintenance
protocols were approved by the Institutional Animal Care and
Use Committee, University of California, Santa Barbara, CA.
One-Step Ultrasonic Sampling Procedure
Earlier studies with ultrasound focused on sampling
interstitial fluid through a two-step process: permeabilizing
the skin by ultrasound and subsequently applying vacuum
to collect interstitial fluid. In this study, we describe a new
direct sampling approach where skin constituents are
collected into the ultrasound coupling medium during the
sonication procedure itself. In vitro experiments were carried
out by a brief application of ultrasound (20 kHz, 2.4 W/cm
2,
50% duty cycle, Sonics & Materials, Newtown, CT) to skin
mounted on a Franz diffusion cell assembly (skin exposure
area of 1.77 cm
2; Permegear, Hellertown, PA). The
receiver chamber of the diffusion cells was filled with
phosphate-buffered saline (PBS) (P4417, Sigma-Aldrich, St.
Louis, MO), and the donor chamber was filled with 1 ml of
sampling medium (1% w/v sodium lauryl sulfate (SLS) in
sterile PBS), which also functioned as the coupling fluid
between the ultrasound transducer and skin. For in vivo
experiments, animals were anesthetized with 1.25–4%
isofluorane in oxygen and, shaved on the abdomen or back
with a clipper, and a custom-made flanged chamber (skin
exposure areaof1.33cm
2) was glued to the shaven area with
a cyanoacrylate-based adhesive. The chamber was filled with
1.5 ml of sampling medium. Transepidermal current was
measured by applying 143 mV AC signal at 10 Hz (33120A,
Agilent, Santa Clara, CA) across the sonicated skin to
determine the extent of skin permeabilization. For in vitro
experiments, electrodes (4-mm Ag/AgCl disk electrode,
Invivo Metrics, Healdsburg, CA) were inserted in the donor
and receiver chambers of the Franz diffusion cell assembly.
Onlythoseskinpieceshavinganinitialresis tivityof30kΩ-cm
2
or more were used in the experiments. For in vivo experi-
ments, an electrode was introduced in the sampling medium,
and a subcutaneous reference was used as the counter
electrode. Should this method be applied to humans, a
subcutaneous reference will not be necessary and can be
replaced by a topical patch electrode. Initial rat skin
resistivity was about 100 kΩ-cm
2.A2 0 - f o l di n c r e a s ei n
transepidermal current (equivalent to about 20-fold decrease
in skin resistivity) was chosen in this study as a threshold to
stop ultrasound application and ensure safety of ultrasound
exposure. A 20-fold increase in skin conductivity typically
required about 5 min of ultrasound exposure at 50% duty
cycle. All experiments were carried out at room temperature.
Ultrasonic exposure is often associated with thermal effects.
The magnitude of thermal effects depends on several
parameters, including ultrasound intensity, duty cycle,
exposure time, and volume of the sampling medium. While
a moderate temperature increase is acceptable, these effects
were minimized so as to avoid confounding contributions by
thermal and mechanical effects. As such, ultrasound under
the conditions used in this study has been previously used in
humans without any adverse thermal effects (22). During the
sampling procedure, care was taken to minimize the thermal
effects of ultrasound on skin. The temperature of the
sampling medium was monitored after each minute of
ultrasound exposure using a thermocouple. If temperature
of the medium increased over 5°C, the sampling medium
was aspirated in a centrifuge tube and briefly chilled over an
ice bath for 1 min. Most of the experiments did not require
temperature modulation; however, when necessary, a single
cooling procedure was sufficient. After the completion of the
sonication procedure, sampling medium was immediately
aspiratedusingaPasteurpipetteandstoredat−20°Cforlater
analysis of the collected analytes.
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molecules retrieved by ultrasonic sampling with the actual
composition of molecules present in the skin, epidermal skin
homogenate samples were prepared from heat-stripped
epidermal (stratum corneum and viable epidermis) porcine
skin. Skin was heat-stripped using a microwave oven for 5 s,
and full epidermis was carefully stripped off from the skin
using a pair of tweezers.
Analysis of Natural Moisturizing Factors
Ultrasonic samples (n=5) were analyzed to quantify the
presence of natural moisturizing factors. Epidermal homo-
g e n a t e sw e r eu s e da sp o s i t i v ec o n t r o l s( n=5). Passive
sampling was performed by incubation of the sampling
medium with skin for 5 min (n=5). The samples were
deproteinized by adding 2.5% v/v (final concentration)
trichloroacetic acid followed by centrifugation to retrieve
the acid-soluble supernatants (as previously described in
Ref. (23)). Acid in the samples was then neutralized to pH 7.2
byadding 1N NaOH. Aminoacidanalysisofthesampleswas
done by ion exchange HPLC with ninhydrin-based detection
system (6300 Auto Analyzer, Beckman Coulter, Fullerton,
CA), and absorbance was processed by HP ChemStation
(A.06.03(509), Hewlett-Packard, Wilmington, DE) in external
standard mode using a standard amino acid mixture (AAS18,
Sigma-Aldrich, St. Louis, MO). Specifically, aspartic acid
(asp), threonine (thr), serine (ser), glutamic acid (glu), proline
(pro), glycine (gly), alanine (ala), cysteine (cys), valine (val),
methionine (met), isoleucine (ile), leucine (leu), phenylalanine
(phe), tyrosine (tyr), histidine (his), lysine (lys), and arginine
(arg) were analyzed. UV-Visual spectroscopy-based commer-
cialkitswereboughtandusedaccordingtothemanufacturer’s
instruction, for the quantification of lactic acid (K-DLATE,
Megazyme, Wicklow, Ireland; n=4) and urea (DIUR-500,
BioAssay Systems, Hayward, CA, n=4) in the samples.
Delivery and Detection of Drugs in Skin
In vitro experiments on porcine skin were designed using
Franz diffusion cells to assess delivery of radiolabeled
docosanol (log P: 10.5, Molecular weight: 326.57 Da; ART
0449, American Radiolabeled Chemicals, St. Louis, MO) in
the skin. Docosanol was topically delivered by applying the
drug solution in PBS for 4 h (donor drug concentration:
10 μCi/ml). At the end of the experiment, to ensure removal
of residual drug on skin, the formulation was aspirated from
the donor chamber, and the chamber was briefly washed by
repeatedly dispensing and aspirating 1 ml of saline with a
Pasteur pipette. This procedure was repeated three times
with fresh saline. Skin was tape-stripped (Scotch® Magic™
tape, 3 M, St. Paul, MN) two times to further remove
residual drug on the skin. These tape strips were discarded
and not included in the drug analysis. Skin was sampled
ultrasonically (n=3) as described above or with tape stripping
(n= 3 )i ns e p a r a t ee x p e r i m e n t s .D e c r e a s ei ns k i n ’se l e c t r i c a l
impedance was used as an indirect measure for the amount
of stratum corneum sampled by tape-stripping procedure.
Saturation in the decrease of skin’s electrical resistivity after
each tape strip—defined as less than 10% decrease in
electrical resistivity between two sequential tape strips and
representative of nearly complete removal of stratum
corneum—was chosen as the endpoint of the tape-stripping
procedure. For the batch of abdominal porcine skin used in
the in vitro experiments, it took about 25 tape strips to reach
saturation. Tape strips wereanalyzedinfivegroupsconsisting
of five tapes each. Each group of tapes was incubated
overnight with 5 ml of tissue solvent (Solvable, Catalog No.
6NE9100,PerkinElmer,Waltham,MA)atroomtemperature
to extract drug from the tapes. Extraction efficiency of this
procedure was determined to be 93.1±7.3%. Passive sam-
pling (n=3) was also performed by incubating the sampling
medium for 5 min with skin.
In two additional sets of experiments, docosanol was
subdermally delivered for either 8 h or 24 h by adding drug
solution in the receiver compartment of the diffusion cell
(receiver drug concentration: 1 μCi/ml). After the drug was
delivered, ultrasonic sampling (n=3) and passive sampling
(n=3) were performed from the donor chamber. Tape-
stripping procedure (total 25 tape strips, n=3) was also per-
formed. Since drug was not introduced in the donor, initial
tapes were not discarded and were included in the analysis.
For in vivo drug bioavailability assessment, Sprague
Dawley rats were placed in a wire mesh cage which
allowed animal excreta to be collected in a separate plate
placed underneath the cage. Such an arrangement mini-
mized contamination of skin with urine. Rats were
intravenously administered with 10 mg/kg fluconazole
along with 250 μCi/kg of radiolabeled fluconazole (log P:
0.4, Molecular weight: 306.27 Da; MT 1752, Moravek
Radiochemicals, Brea, CA) or 5 mg/kg cocaine along with
175 μCi/kg of radiolabeled cocaine (log P: 2.3, Molecular
weight: 303.35 Da; ART 0651, American Radiolabeled
Chemicals, St. Louis, MO) by tail vein injections in two
separate experiments. Since dosage directly affects the rate
of drug metabolism and its distribution in vivo,n o n -
radiolabeled drug was added to the formulation to administer
physiologically relevant doses of fluconazole and cocaine in
animals. The drugs were sampled from the back of the
animals at various times after the injection, with each
sampling performed at a different skin site. Nine experiments
were performed corresponding to three animals and three
distinct skin sites per animal. Urine samples and blood
samples (drawn through the jugular vein) were also simulta-
neously collected to compare with ultrasonic skin sampling
technique. Topical skin swabs were carried out as a passive
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mixtureofwaterandethanol,andcynoacrylatetape-stripping
was done to collect drug from the full epidermis.
Statistical Analysis
Student’s t-test was applied to test if there were any significant
differences between the amount of molecules sampled by
ultrasound and different types of samples, such as skin homog-
enate, blood, urine and samples retrieved by tape stripping.
RESULTS
Sampling of Endogenous Small Molecules of Skin
The ability of ultrasound to sample endogenous epidermal
biomolecules from skin was assessed in vitro.F o rt h i sp u r p o s e ,
we focused on assessing the presence of natural moisturizing
factors (NMFs) in skin. NMFs are comprised of many
molecules, of which free amino acids, lactate and urea that
collectively constitute over 60% w/w of the total NMFs
present in the skin (24), were detected in this study. A
quantitative analysis was performed to compare ultrasonically
sampled amino acids with their native composition profile in
the epidermal skin. Table I shows the concentration (nmole
per cm
2 skin) of 16 most abundant free amino acids in
ultrasound sample, passive sample and epidermal skin
homogenate. With the exception of glutamic acid and
arginine (p<0.05, Student’s t-test, n=5), a good overall
correlation between the relative amount of amino acids (%
mole/mole) in the ultrasonic sample and epidermal homog-
enate was observed. Ultrasound sampled 15.7±4.7% of
amino acids present in the epidermal skin. Only 7 amino
acids were sampled passively and at much lower concen-
trations as compared with ultrasound samples. Other NMFs,
including lactic acid and urea were also detected in the
ultrasound sample of porcine skin at concentrations of 41.82±
26.65 nmole/cm
2 and 13.92±5.07 µmole/cm
2,r e s p e c t i v e l y .
Assessment of Drug Delivered to Skin After Topical
and Systemic Administration
The ability of the ultrasonic sampling method to determine the
amount of drug accumulated in the skin was assessed. A model
drug, docosanol, was first topically delivered for 4 h into
porcine skin mounted on a Franz diffusion cell and was later
sampled using ultrasound. Ultrasound recovered 79±13% of
the drug accumulated in the epidermis, as determined by the
drug concentration in the epidermis homogenate (n=5). Effec-
tiveness of ultrasonic sampling was compared with that of the
tape-stripping technique. A significant amount of docosanol
was collected in the first five strips; however, the cumulative
amount of docosanol sampled by 25 tape strips was only 40%
of that sampled by ultrasound (p<0.001, Student’s t-test, n=3;
Fig. 1a). Higher recovery of docosanol by ultrasound suggests
Table I Amount of Amino Acids Present in Epidermal Homogenate and in Samples Acquired by Passive Sampling and Ultrasonic Sampling
AA AA sampled by ultrasound AA in epidermal homogenate AA sampled passively (nmol/cm
2)
(nmol/cm
2) % (mole/mole) (nmol/cm
2) % (mole/mole)
asp 3.7±1.0 3.5±1.2 32.0±19.0 4.2±1.5 2.4±0.6
thr 5.5±1.9 5.1±1.5 49.8±15.0 7.1±2.7 2.1±0.6
ser 19.0±9.9 17.8±8.8 161.7±18.3 23.2±4.5 7.3±1.3
glu 4.5±1.1 4.2±0.7
a 45.5±14.3 6.3±1.5 2.5±0.5
pro 4.4±4.4 3.1±3.8 20.3±25.6 2.6±2.9 nd
gly 22.3±8.4 20.6±7.0 113.9±40.7 15.7±3.3 6.4±1.1
ala 9.5±2.0 8.9±1.6 63.4±21.4 8.7±1.5 2.9±0.4
val 4.1±2.4 4.1±3.1 21.2±9.7 2.8±0.7 nd
met 2.0±2.2 1.5±2.0 3.7±2.6 0.5±0.2 nd
ile 3.1±2.1 2.8±1.7 12.8±4.4 1.8±0.4 2.6±0.6
leu 2.9±0.7 2.7±0.7 22.5±8.2 3.1±0.9 nd
phe 2.9±0.9 2.1±1.4 18.4±13.2 2.4±1.1 nd
tyr 2.0±0.7 1.4±0.9 12.9±5.4 1.8±0.6 nd
his 8.4±2.5 7.9±2.2 62.8±25.3 9.3±4.8 nd
lys 5.0±2.4 4.7±2.1 27.1±24.6 3.4±2.2 nd
arg 10.4±3.2 9.6±2.2
a 51.2±10.3 7.2±0.7 nd
AA amino acid; nd not detectable;
asignificant difference between %(mole/mole) amount of amino acid sampled by ultrasound and amino acid present in
epidermal homogenate (p<0.05, student’s t test)
Paliwal, Ogura and Mitragotri 1258that a significant amount of docosanol was delivered into viable
epidermis, which was accessible to ultrasound.
To assess the potential of ultrasound to sample systemically
delivered drugs, additional experiments were performed in
vitro, where systemic delivery was mimicked by including
docosanol in the receiver compartment of diffusion cells for
either 8 or 24 h in separate experiments. The skin was
sampled by sequential tape stripping and ultrasonic sampling
to compare sampling efficiency and temporal sampling
resolution of the two methods. Sequential tape stripping
yielded relatively constant amounts of docosanol in all tapes,
suggesting homogeneous drug distribution in the stratum
corneum. Neither the amount of drug sequentially retrieved
by each tape, nor the cumulative amount of drug sampled by
tapestripping fromskintissues incubated for 8 and24 h,were
statistically different (Student’s t-test, n=3, Fig. 1b). At both
time points, however, ultrasonic sampling recovered greater
amounts of docosanol compared to tape stripping, and a
temporal sampling resolution was attained (p<0.01, Student’s
t-test, n=3, Fig. 1b). Passive sampling conducted by incuba-
tion of sampling buffer with skin retrieved significantly lower
amount of docosanol compared with tape stripping and
ultrasonic sampling (p<0.05, Student’s t-test, n=3, Fig. 1b).
The aim of the in vitro experiments was to demonstrate the
proof-of-concept of ultrasonic sampling, and systemic effects
such as drug clearance from skin, as relevant in a practical
situation, could not be evaluated in the in vitro analysis.
Therefore, the effectiveness of ultrasonic sampling was tested
in vivo using an anti-fungal drug, fluconazole, which is known
to accumulate in skin after intravenous administration (3,25).
These experiments were performed in Sprague Dawley rats
over a period of seven days. Blood samples were collected to
measure plasma fluconazole concentration as a reference.
Tape-stripping sampling was performed as a positive control,
and skin swabs were used as a passive control. Fluconazole
disappeared quickly from blood, and less then 0.15% of the
drug remained in blood after 1 day as compared to its initial
amount at 1 h after intravenous injection. Consistent with
preferential partitioning of fluconazole in skin (25), ultrasonic
sampling revealed a higher residence time of the drug in skin
(Fig. 2). About 30% of the drug still remained in skin after
7 days compared to its initial amount at 6 h after drug
administration. Recovery of fluconazole from skin by tape
stripping was significantly lower than that by ultrasonic
sampling over the 7-day period (p<0.05 for sampling at ≥
2 days, Student’s t test, n=9; Fig. 2). Skin swabs yielded even
lower recovery of drug from the skin.
Prolonged Forensic Detection of Cocaine in Skin
As another potential application, ultrasonic sampling was
performed to detect cocaine from skin. Cocaine was
intravenously injected in rats, and its concentration in
a
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Fig. 1 In vitro sampling efficiency assessment and comparison of
ultrasonic sampling method with tape stripping technique for topical and
systemic drug delivery was performed. (a) Docosanol was topically
delivered to porcine skin for 4 h. Decreasing amounts of drug were
sampled by sequential tape strippings (five strips are grouped together into
one data point), implying that most of the drug was accumulated
superficially. Cumulative amount of drug sampled by tape stripping
technique was found to be significantly less than the drug sampled by
ultrasound procedure (2.42-fold, p<0.001). (n=3). (b) To mimic
systemic delivery in vitro, docosanol was subdermally delivered from the
receiver compartment of diffusion cells for 8 or 24 h. Neither the amount
of drug sequentially retrieved by each additional tape stripping, nor the
cumulative amountof drug sampled by fulltape strippingprocedure fromskin
tissues was statistically different between 8 and 24 h. Ultrasonic sampling was
more sensitive than tape stripping in its ability to temporally distinguish
between drugs sampled from skin at the two different times. (n=3).
1259 Rapid Sampling of Molecules via Skinurine was followed for 7 days. Fig. 3 shows the total amount
of cocaine present in urine and the entire rat skin (as
determined from the amount recovered by ultrasonic
sampling from a known area). Less than 0.15% of cocaine
was detected in urine on day 7 compared to the initial
amount present on day 1 (8 h). Although the amount of
drug initially present in urine was 5.87-fold higher than in
skin, a relatively sustained presence of cocaine was seen in
skin over a period of 7 days. A high fraction of cocaine
(26.85%) still remained in skin on day 7 compared to its
initial amount at 8 h after cocaine administration. On day
7, the amount of cocaine present in urine was significantly
lower (p<0.05, student’s t test, n=9) than the amount
measured by passive sampling of skin (wipe). In contrast,
ultrasonic sampling revealed about 12-fold higher cocaine
presence in skin compared with passive sampling on day 7.
DISCUSSION
Ultrasound has been previously used to harvest skin’s
interstitial fluid in a two-step process—permeabilization
followed by vacuum-assisted collection (21,26,27). In this
study, we demonstrate that several diagnostically and
therapeutically relevant molecules can be rapidly sampled
by a brief exposure of ultrasound directly into the ultrasonic
coupling medium, thereby avoiding the need to solubilize
and disperse analytes in a liquid as is required in
conventional methods, including tape stripping.
Table I presents the amount of 16 amino acids sampled
by ultrasound and in epidermal homogenate. Except for
glutamic acid and arginine, a good correlation between
the relative amount of amino acids (% mole/mole) in the
ultrasonic sample and epidermal homogenate was obtained,
which suggests that ultrasonic sampling captured the compo-
sition profile of amino acids in the epidermal skin. The
concentrations of various amino acids sampled by ultrasound
are consistent with the amount sampled by another skin
sampling method—reverse iontophoresis (28). Consistent
with observations of Bouissou et al. (28), amino acids sampled
by ultrasound can be subdivided in two groups: (a) amino
acids present at high concentrations in epidermal skin (ser,
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technique was performed. Ten mg/kg of fluconazole (amounting to
250 μCi/kg of radioactivity) was intravenously administrated in rats.
Fluconazole cocncentration (ng/cm
2) in the ultrasonic, tape stripping and
swab samples was determined by measuring the total radioactivity (μCi) of
the samples and normalizing them by skin sampling area (1.33 cm
2).
Blood levels of fluconazole (closed squares) rapidly decreased within 24 h;
however, ultrasonic sampling (closed circles) revealed prolonged retention
of fluconazole in the skin. Fluconazole was detected in the skin by
ultrasound for over 7 days, which was also confirmed by tape stripping
technique (open circles); however, ultrasound sampled significantly higher
amounts of fluconazole than by tape stripping (indicated by (*): p<0.05,
student’s t-test). Skin swabs (open squares) sampled significantly lower
amounts of fluconazole than tape stripping and ultrasonic sampling
(p<0.05, Student’s t-test). (n=9, corresponding to three animals and
three distinct skin sites within each animal.)
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Fig. 3 Forensic detection of cocaine by ultrasonic sampling from skin was
assessed. Five mg/kg of cocaine (amounting to 175 μCi/kg of radioactivity)
was intravenously administrated in rats. Concentration of cocaine (ng/cm
2)
in the ultrasonic and swab samples was determined by measuring the total
radioactivity (μCi) of the samples and normalizing them by skin sampling
area (1.33 cm
2). The total amounts of cocaine in skin available to
ultrasonic sampling and swabbing were calculated by multiplying respective
measured cocaine concentration (ng/cm
2) with total body skin area of the
rats (determined by mech’s formula: A = kW
2/3, where A is the body’s
skin area in cm
2, W is the body weight in grams and k=10). The total
amount of cocaine in urine was determined by measuring cocaine
concentration in urine at specific times and multiplying it by the total urine
volume excreted at that time. The total amounts of cocaine present in
urine (the conventional sample of choice) and in skin were monitored
over a course of 7 days. Cocaine levels fell rapidly to less than 0.15% of
the initial amount in urine (closed circle); however, amount of cocaine in
skin that was available to ultrasonic sampling (open circles) showed a
sustained presence of the drug in skin for up to 7 days (* indicates p<
0.05 for student’s t-test: urine vs. skin drug amount). (n=9,
corresponding to three animals and three distinct sites within each animal.)
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2 and (b) amino acids
present at moderate to low concentrations (thr, lys, glu, pro,
val asp, ile, phe, leu, met and tyr; 5-1 nmole/cm
2). Other
physiological amino acids were detected neither in ultrasound
sample nor in the epidermal homogenate. Seven amino acids
(gly, ser, ala, thr, glu, asp and ile) were sampled passively in
our study. Except for isoleucine, all passively sampled amino
acids were present in a significantly lower concentration than
that in the ultrasonic sample (p<0.05, Student’s t test, n=5,
Table I). In contrast, Bouissou et al. reported that all amino
acids sampled by reverse iontophoresis were also sampled in
comparable amounts passively. This difference can be due to
significant difference in passive sampling time between the
two studies (6 h in the reverse iontophoresis study (28)
compared with 5 min in this study). Nevertheless, the ability
to passively sample amino acids suggests intercellular origin
of a majority of amino acids; however, further studies are
needed to determine the origin of amino acids sampled by
ultrasound (intracellular or intercellular).
In addition to amino acids, ultrasound also sampled
two other NMFs—lactic acid and urea at concentrations
consistent with those previously reported in the literature.
Specifically, Nixon et al. (29) reported sampling of about
168 nmoles/cm
2 of lactate in 5 h from porcine skin using
reverseiontoporesis,comparedwith41.82±26.65nmole/cm
2
sampled by ultrasound in this study (lactic acid amount was
determined from Ref. (29) by integration of iontophoretic
molar flux over time). Similarly, ultrasound sampled 13.92±
5.07 µmole/cm
2 urea, which is in agreement with
5.97 µmole/cm
2 urea sampled in rat skin by ultrasound/
vacuum-assisted sampling procedure in a separate study (21).
Reverse iontophoresis sampled about 40 nmoles/cm
2 in 6 h
from porcine skin (30).
Fig. 1 shows ultrasonic sampling of a model drug,
docosanol, delivered to skin either topically or subdermally
in vitro. Irrespective of the mode of delivery, ultrasonic
sampling collected higher amounts of drug molecules from
skin compared to tape stripping. A possible explanation for
this observation is that ultrasound collects drugs from the
epidermis as opposed to tape stripping, which samples from
the stratum corneum. Notably, biophysical effects of
ultrasound on skin are known to manifest well into the
epidermis (31), suggesting that ultrasound can access
molecules present in epidermis. Fig. 1b shows that the
difference in the amount of drug present in stratum
corneum after 8 h and 24 h of subdermal docosanol
delivery was statistically insignificant; however, ultrasound
sampled significantly more amount of drug from skin at 24 h
compared to 8 h. This difference is likely to originate from
the difference in docosanol concentration in the epidermis
and dermis layers at 24 h compared to 8 h, implying that
ultrasound samples deeper layers of skin. This result,
however, is surprising considering dermis is highly perme-
able to hydrophilic solutes. The temporal difference in the
amount of docosanol in dermis and epidermis may result
from docosanol’s high lipophilicity (logP=10.5) leading to
diffusion-limited transport of docosanol in dermis and
epidermis. This is supported by 1.66-fold higher amount of
docosanal present in skin at 24 h compared with 8 h (n=6).
In agreement with in vitro results, Fig. 2 shows that
ultrasound offers an attractive means of sampling drugs
from deeper layers of skin and over a long period of time.
Determination of pharmacokinetic profiles of drugs that
therapeutically target deeper viable layers of skin underly-
ing the stratum corneum remains a major focus of US-FDA
(13,32); therefore, ultrasonic sampling may provide a
patient-friendly and rapid method for determining phar-
macokinetic profiles of drugs having therapeutic targets in
skin layers other than stratum corneum. However, before
reliable quantification of pharmacokinetic profiles can be
made, several key parameters of ultrasonic sampling have
to be determined. For example, studies that would establish
control of ultrasonic sampling depth in the skin, determine
ultrasonic sampling efficiency for different layers of skin
(stratum corneum, epidermis and dermis), and determine
molecule-specific sampling efficiency are warranted. Final-
ly, studies to determine ultrasonic sampling parameters for
translation of this study’s in vivo results to humans have to be
established. One such key parameter is the amount of drug
sampled by ultrasound and whether it is above the
detection limit of the drug assay. Such extrapolation also
requires a consideration for skin/body mass ratio of the
animal model and its relationship to that in humans.
Fig. 3 demonstrates that ultrasonic sampling of accumu-
lated illicit drugs in skin can potentially provide significant
benefits over current methods, including urinalysis—the
present method of choice. Urine sampling has several
limitations, including short window of detection (1–3 days)
and privacy concerns leading to unsupervised sampling and
susceptibility to tampering (33,34). Alternative approaches,
such as sweat-collection skin patches and drug detection in
hair, have been also proposed (35). Sweat patches provide
user convenience but have to be worn for a long time (more
than a day), often in unsupervised setting, before detectable
quantities of sweat can be collected (34). Additionally, both
hair and sweat-patch testing require dispersion of the
collected drug in a liquid sample before drug analysis can
be performed. This makes these approaches time-intensive
and incompatible with onsite testing (36). In contrast,
herein, we describe ultrasonic sampling as a rapid method
which directly generates a liquefied sample for onsite drug
analysis. Ultrasonic sampling can be performed in a
supervised setting and bears no privacy concerns during
sampling for users, making this method impervious to
tampering. As such, skin’s high accessibility and sustained
presence of drug in skin over a long period of time makes it
1261 Rapid Sampling of Molecules via Skinan attractive matrix for forensic detection. However,
concerns over skin’s susceptibility towards environmental
contamination have been presented in a recent study (37)
and have to be addressed to make this matrix viable for
forensic use. Combinatorial approaches, such as discarding
superficial stratum corneum by tape stripping followed by
sampling deeper underlying skin tissue by ultrasonic sampling
or reverse iontophoresis, may help overcome this challenge.
CONCLUSIONS
We demonstrate that skin constituents can be directly and
rapidly sampled using ultrasound. Ultrasonic exposure to
skin at conditions used in this study has a history of clinical
safety (38). Studies have shown that the skin barrier
recovers to baseline values within 20 h of ultrasound
application (21). Additionally, tolerance of low-frequency
ultrasound by patients has also been reported in a number
of clinical studies (39,40). Ultrasonic sampling offers several
advantages, including non-invasive accessibility to deeper
layers of skin and enhanced temporal sampling sensitivity;
however, further studies are required to completely
establish this method, particularly for conducting pharma-
cokinetic studies on skin. Future studies must focus on
building mechanistic understanding so as to exploit the
diverse opportunities that this method provides in the field
of diagnostics and therapeutic monitoring.
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